PREDICTIVE TECHNOLOGY GROUP INC (OTCMKTS:PRED) noted an increase of 317.05% in short interest. In March was published PRED’s total 53,800 short interest by FINRA. That’s 317.05% up from 12,900 shares. 0 days will cost PRED with 329,700 average volume to recover its former position.
Ticker’s shares touched $2.995 during the last trading session after 7.73% change.Currently Predictive Technology Group, Inc. is after 0.00% change in last March 27, 2018. PRED has shares volume. The stock underperformed the S&P 500 by 4.37%.
Predictive Technology Group, Inc., through its subsidiary, Predictive Therapeutics, Inc., engages in the commercialization of therapeutics leveraged by proprietary gene companion diagnostics for the treatment of serious and debilitating diseases.The firm is worth $745.29 million. It primarily offers EndoRisk, a companion diagnostic/genetic test for endometriosis.Last it reported negative earnings. The firm is also developing NHP-07, a pharmaceutical/therapeutic candidate for the treatment of endometriosis; genetic scoliosis test for the diagnosis of scoliosis; and test for degenerative disc disease.
For more Predictive Technology Group, Inc. (OTCMKTS:PRED) news published briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Longfin’s Acquisition Of Ziddu.Com Added Over $2 Billion To Its Current Valuation, But We Found It To Have Little Value – Seeking Alpha” published on March 15, 2018, “Predictive Technology (PRED) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference – Slideshow – Seeking Alpha” on September 06, 2018, “Roche Holding Ltd ADR 2018 Q1 – Results – Earnings Call Slides – Seeking Alpha” with a publish date: April 26, 2018, “Roche Holding Ltd ADR 2016 Q3 – Results – Earnings Call Slides – Seeking Alpha” and the last “Roche Holding Ltd ADR 2016 Q2 – Results – Earnings Call Slides – Seeking Alpha” with publication date: July 21, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.